{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:42:04Z","timestamp":1792813324643,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"The Leona M and Harry B Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Structural Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.crstbi.2026.100199","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:13:29Z","timestamp":1791875609000},"page":"100199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-guided computational design and mechanistic understanding of the p95HER2-targeting NAZ-mAb antibody and its variants"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-8081","authenticated-orcid":false,"given":"Puneet","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2854-3694","authenticated-orcid":false,"given":"Jon Amund","family":"Kyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2622-5032","authenticated-orcid":false,"given":"Victor","family":"Greiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1619-6610","authenticated-orcid":false,"given":"Esmaeil","family":"Dorraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42003-023-04927-7","article-title":"ImmuneBuilder: deep-learning models for predicting the structures of immune proteins","volume":"6","author":"Abanades","year":"2023","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.2008790","article-title":"Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies","volume":"14","author":"Akbar","year":"2022","journal-title":"mAbs"},{"issue":"13","key":"10.1016\/j.crstbi.2026.100199_bib3","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1038\/sj.emboj.7601191","article-title":"Biosynthesis of tumorigenic HER2 C-Terminal fragments by alternative initiation of translation","volume":"25","author":"Anido","year":"2006","journal-title":"EMBO J."},{"issue":"21","key":"10.1016\/j.crstbi.2026.100199_bib4","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1021\/acs.jpcb.7b11367","article-title":"Flex ddG: rosetta ensemble-based estimation of changes in protein-protein binding affinity upon mutation","volume":"122","author":"Barlow","year":"2018","journal-title":"J. Phys. Chem. B"},{"issue":"20","key":"10.1016\/j.crstbi.2026.100199_bib5","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/bioinformatics\/bts493","article-title":"Application of asymmetric statistical potentials to antibody\u2013protein docking","volume":"28","author":"Brenke","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-cancerbio-060220-014137","article-title":"Molecular heterogeneity and evolution in breast cancer","volume":"5","author":"Caswell-Jin","year":"2021","journal-title":"Ann. Rev. Cancer Biol."},{"issue":"13","key":"10.1016\/j.crstbi.2026.100199_bib7","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1158\/1078-0432.CCR-17-1864","article-title":"High p95HER2\/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-Positive metastatic breast cancer NCCTG N0337 and NCCTG 98-32-52 (alliance)","volume":"24","author":"Chumsri","year":"2018","journal-title":"Clin. Cancer Res.: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.crstbi.2026.100199_bib15","article-title":"Effects of protein interface mutations on protein quality and affinity","author":"de Kanter","year":"2026","journal-title":"bioRxiv. BioRxiv"},{"issue":"20","key":"10.1016\/j.crstbi.2026.100199_bib8","first-page":"4168","article-title":"FoldX 5.0: working with RNA, small molecules and a new graphical interface","volume":"35","author":"Delgado","year":"2019","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"7","key":"10.1016\/j.crstbi.2026.100199_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/protein\/gzl016","article-title":"Engineering stability into Escherichia Coli secreted fabs leads to increased functional expression","volume":"19","author":"Demarest","year":"2006","journal-title":"Protein Eng. Des. Sel."},{"issue":"19","key":"10.1016\/j.crstbi.2026.100199_bib10","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.3390\/cancers14194859","article-title":"Development of a high-affinity antibody against the tumor-specific and hyperactive 611-p95HER2 isoform","volume":"14","author":"Dorraji","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.crstbi.2026.100199_bib11","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1002\/prot.24634","article-title":"A multiscale approach to predicting affinity changes in protein-protein interfaces: multiscale method for predicting \u0394\u0394G","volume":"82","author":"Dourado","year":"2014","journal-title":"Proteins"},{"issue":"11","key":"10.1016\/j.crstbi.2026.100199_bib12","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"issue":"May","key":"10.1016\/j.crstbi.2026.100199_bib13","article-title":"Hydrogen deuterium exchange and other Mass spectrometry-based approaches for epitope mapping","volume":"3","author":"Jethva","year":"2023","journal-title":"Front. Anal. Sci."},{"issue":"7873","key":"10.1016\/j.crstbi.2026.100199_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108072","article-title":"Epitope mapping via in vitro deep mutational scanning methods and its applications","volume":"301","author":"Keen","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.crstbi.2026.100199_bib17","article-title":"ABodyBuilder3: improved and scalable antibody structure predictions","volume":"40","author":"Kenlay","year":"2024","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"4","key":"10.1016\/j.crstbi.2026.100199_bib18","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/protein\/8.1.81","article-title":"Engineered turns of a recombinant antibody improve its in vivo folding","volume":"8","author":"Knappik","year":"1995","journal-title":"Protein Eng."},{"issue":"6693","key":"10.1016\/j.crstbi.2026.100199_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl2528","article-title":"Generalized biomolecular modeling and design with RoseTTAFold all-atom","volume":"384","author":"Krishna","year":"2024","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.crstbi.2026.100199_bib21","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/19420862.2016.1205773","article-title":"ABodyBuilder: automated antibody structure prediction with data\u2013driven accuracy estimation","volume":"8","author":"Leem","year":"2016","journal-title":"mAbs"},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib22","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1038\/s41467-022-31457-3","article-title":"Co-Optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space","volume":"13","author":"Makowski","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/bioadv\/vbac046","article-title":"AbLang: an antibody Language model for completing antibody sequences","volume":"2","author":"Olsen","year":"2022","journal-title":"Bioinform. Adv."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3816\/CBC.2004.n.011","article-title":"HER2 amplification ratios by Fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues","volume":"5","author":"Owens","year":"2004","journal-title":"Clin. Breast Cancer"},{"issue":"12","key":"10.1016\/j.crstbi.2026.100199_bib25","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/MCB.01803-08","article-title":"A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis","volume":"29","author":"Pedersen","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.crstbi.2026.100199_bib26","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/bioinformatics\/btu097","article-title":"ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers","volume":"30","author":"Pierce","year":"2014","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.crstbi.2026.100199_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/protein\/gzp030","article-title":"Assessing computational methods for predicting protein stability upon mutation: good on average but not in the details","volume":"22","author":"Potapov","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"issue":"11","key":"10.1016\/j.crstbi.2026.100199_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.11.006","article-title":"ANuPP: a versatile tool to predict aggregation nucleating regions in peptides and proteins","volume":"433","author":"Prabakaran","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s42003-023-05744-8","article-title":"Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling","volume":"7","author":"Raybould","year":"2024","journal-title":"Commun. Biol."},{"issue":"15","key":"10.1016\/j.crstbi.2026.100199_bib30","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016239118","article-title":"Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences","volume":"118","author":"Rives","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pro.3942","article-title":"DynaMut2: assessing changes in stability and flexibility upon single and multiple point missense mutations","volume":"30","author":"Rodrigues","year":"2021","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.crstbi.2026.100199_bib32","first-page":"155","article-title":"Affinity and avidity in antibody-based tumor targeting","volume":"24","author":"Rudnick","year":"2009","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38063-x","article-title":"Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies","volume":"14","author":"Ruffolo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crstbi.2026.100199_bib34","article-title":"Deciphering antibody affinity maturation with Language models and weakly supervised learning","author":"Ruffolo","year":"2021","journal-title":"arXiv [q-bio.BM]"},{"issue":"July","key":"10.1016\/j.crstbi.2026.100199_bib35","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.csbj.2020.07.011","article-title":"Limitations and challenges in protein stability prediction upon genome variations: towards future applications in precision medicine","volume":"18","author":"Sanavia","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12859-023-05537-0","article-title":"Statistical modeling to quantify the uncertainty of FoldX-Predicted protein folding and binding stability","volume":"24","author":"Sapozhnikov","year":"2023","journal-title":"BMC Bioinf."},{"issue":"8","key":"10.1016\/j.crstbi.2026.100199_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnci\/djk134","article-title":"Expression of p95HER2, a truncated form of the HER2 receptor, and response to Anti-HER2 therapies in breast cancer","volume":"99","author":"Scaltriti","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib38","article-title":"Cancer Statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.crstbi.2026.100199_bib39","article-title":"Structural plausibility without binding specificity: limits of AI-Based antibody-antigen structure prediction confidence scores","author":"Smorodina","year":"2026","journal-title":"bioRxiv. BioRxiv"},{"issue":"16","key":"10.1016\/j.crstbi.2026.100199_bib40","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1158\/1078-0432.CCR-10-0410","article-title":"Quantitation of p95HER2 in paraffin sections by using a p95-Specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients","volume":"16","author":"Sperinde","year":"2010","journal-title":"Clin. Cancer Res.: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.crstbi.2026.100199_bib41","article-title":"Evaluating FoldX5.1 for MAVISp stability data collection","author":"Vliora","year":"2026","journal-title":"bioRxiv. BioRxiv"},{"issue":"1","key":"10.1016\/j.crstbi.2026.100199_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41467-025-67127-3","article-title":"Benchmarking all-atom biomolecular structure prediction with FoldBench","volume":"17","author":"Xu","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.crstbi.2026.100199_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100939","article-title":"MutaBind2: predicting the impacts of single and multiple mutations on protein-protein interactions","volume":"23","author":"Zhang","year":"2020","journal-title":"iScience"}],"container-title":["Current Research in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665928X26000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665928X26000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:46:28Z","timestamp":1792809988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665928X26000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S2665928X26000206"],"URL":"https:\/\/doi.org\/10.1016\/j.crstbi.2026.100199","relation":{},"ISSN":["2665-928X"],"issn-type":[{"value":"2665-928X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided computational design and mechanistic understanding of the p95HER2-targeting NAZ-mAb antibody and its variants","name":"articletitle","label":"Article Title"},{"value":"Current Research in Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crstbi.2026.100199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100199"}}